Tag: Biopharmaceuticals

With an estimated 65% of the global population experiencing some form of lactose malabsorption, supplements using Nova enzymes, such as lactase, offer a common solution. This article clarifies what Nova enzymes are used for across several distinct contexts, including dietary supplements, biopharmaceuticals, and fundamental genetic mechanisms.

Synthetic proteins are artificially created proteins engineered for specific functions, a feat that is revolutionizing multiple industries. Unlike their natural counterparts, these human-designed molecules offer unparalleled precision and customizability, leading to groundbreaking applications in medicine, biotechnology, and sustainable materials.

Lactulose, a synthetic disaccharide, has been used for over 60 years to treat constipation and hepatic encephalopathy. While many disaccharides are a source of dietary energy, certain ones possess unique biological properties that make them valuable in medical and pharmaceutical applications.

Over 20,000 different proteins are encoded in the human genome. The characterization of a protein is the systematic process of analyzing its physical and chemical properties, structure, and function to understand its role in biological systems.

The global market for engineered protein drugs was estimated at over $387 billion in 2023, showcasing the immense and growing importance of these advanced treatments in modern healthcare. These powerful biological agents, which answer the question, "What does protein medicine do?" are used to treat a wide array of chronic diseases and conditions.

In biopharmaceutical manufacturing, Host Cell Proteins (HCPs) are a critical process-related impurity, with regulatory agencies often requiring levels below 100 parts per million (ppm) in the final drug product. Controlling these impurities is vital, as they can impact product stability, safety, and efficacy. This guide addresses effective strategies on how to reduce host cell proteins throughout the production process.